BiolinqがCGMで$100Mを調達

Biolinq amasses $100M for its painless glucose sensor patch

"We now have an opportunity to expand the sensing category and deliver a new generation of sensing capabilities that can reach millions of lives in the diabetes community and beyond," said Rich Yang, Biolinq’s CEO.

https://www.fiercebiotech.com/medtech/biolinq-amasses-100m-for-its-painless-glucose-sensor-patch